Endovascular Therapy Using Automated Plain CT for Stroke Patients Treated 6 to 72 Hours After Symptoms Start
Led by Santiago Ortega Gutierrez · Updated on 2025-10-16
500
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating endovascular therapy EVT for adults aged 18 to 80 who have suffered an acute ischemic stroke caused by a large blockage in the brains anterior circulation. This phase III global clinical trial tests whether EVT, which removes blood clots from brain arteries, can benefit stroke patients when used up to 72 hours after symptoms start. The study focuses on using a widely available non-contrast CT brain scan analyzed by automated software, instead of advanced imaging, to select patients who may still benefit from treatment.
Participants will be randomly assigned to one of two groups one receiving standard medical care plus EVT, and the other receiving standard medical care alone. EVT involves inserting a catheter through a blood vessel to remove the clot using approved thrombectomy devices, performed by specialized stroke or neurointerventional experts. Treatment is guided by the automated CT software and must begin within 6 to 72 hours of stroke onset. Both groups will be followed with exams and imaging up to 90 days.
During the study, participants will undergo brain imaging, neurological assessments, and evaluations of stroke recovery. Researchers will measure global disability at 90 days using the modified Rankin Scale, along with secondary outcomes like stroke severity changes, brain injury size, reperfusion success, quality of life, and survival. Safety monitoring includes checking for brain bleeding and other adverse events. Functional outcomes are assessed by independent reviewers unaware of treatment assignments to ensure unbiased results.
CONDITIONS
Brief Title
EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
Research Team
S
Santiago Ortega, MD
J
Jorge Cespedes, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Mechanical Thrombectomy plus Standard Care
Standard Medical Management
Current Guideline‑Based Thrombectomy Practice
What it is
Endovascular mechanical thrombectomy plus standard medical care in patients selected by automated non‑contrast CT and imaging criteria (core ≤ 70 cc or ASPECTS ≥ 6) initiated between 6 and 72 hours after stroke onset.
Standard medical management alone using antiplatelets, anticoagulants, blood pressure control, and supportive care per institutional guidelines.
Mechanical thrombectomy within approximately 24 hours in selected patients with favorable imaging profiles is recommended by current guidelines.
Role in trial
Investigational treatment arm randomized to evaluate late‑window thrombectomy.
Active comparator arm receiving best available medical management.
Represents current clinical practice outside trial for selecting patients for thrombectomy in extended windows.
Primary use
To restore blood flow by removing clot in patients beyond standard acute window (6–72 hours from stroke onset) guided by imaging.
Supportive medical care aimed at managing stroke symptoms and preventing complications without endovascular intervention.
To perform thrombectomy within an extended time window in carefully selected patients based on imaging criteria.
How it is given or performed
Mechanical clot retrieval using CE‑approved thrombectomy devices under automated CT guidance, performed within 6 to 72 hours after symptom onset, following device instructions.
Administration of antiplatelets, anticoagulants, blood pressure management, and supportive measures per institutional stroke guidelines.
Performed by trained interventional teams in patients meeting advanced imaging criteria within approximately 24 hours.
Evidence status
Trial is ongoing; results not yet available from this study.
Effectiveness as comparator is being assessed as part of this randomized trial.
Meta‑analysis shows substantially improved functional outcomes with thrombectomy beyond 6 hours compared with medical therapy alone.
Important limitations
No results yet; trial is recruiting and outcomes for this specific late‑window protocol are not yet established.
Same as above – comparator outcomes depend on trial completion.
Guideline recommendations are based on pooled trial data but applicability depends on advanced imaging availability and patient selection.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 80Years
All Genders
Eligibility Criteria
You may qualify if you...
Age between 18 and 80 years
Pre-stroke Modified Rankin Scale (mRS) score of 0-1 for ages 18 to 70; mRS score of 0 for those older than 70
Signs and symptoms of acute ischemic stroke within 24 to 72 hours from last known well
Baseline NIH Stroke Scale score of 8 or greater
Non-contrast CT imaging showing anterior circulation large vessel occlusion by automated software or CT angiography
Core brain tissue damage volume 70 cc or less determined by automated deep learning software or ASPECTS score 6 or higher
Arterial puncture procedure within 72 hours after stroke onset
Arterial puncture within 90 minutes of initial CT scan
Ability to randomize within 72 hours after stroke symptom onset
Signed informed consent from participant or legally authorized representative
You will not qualify if you...
Pregnant females or females of child-bearing potential with positive pregnancy test
Severe allergy to contrast media not controlled by medications
High blood pressure not controlled despite medication (systolic >185 mmHg or diastolic >110 mmHg)
CT evidence of midline brain shift, herniation, intracranial hemorrhage, or mass effect
Bilateral strokes
Clot retrieval attempted less than 6 hours before
Treatment with thrombolytics more than 4.5 hours after last known well
Presence of intracranial tumors
Life expectancy less than 90 days before stroke onset
Participation in another conflicting randomized clinical trial
Suspected septic embolus or bacterial endocarditis
Pre-existing neurological or psychiatric disease affecting evaluations (e.g., dementia with certain medications)
Any condition that prevents endovascular procedure or poses significant risk as judged by investigator
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for imaging and eligibility assessment
Treatment
Duration - Up to 72 hours from stroke onset
Participants receive either endovascular therapy plus standard medical management or standard medical management alone for acute ischemic stroke. Endovascular therapy involves a mechanical thrombectomy procedure performed within 6 to 72 hours after stroke onset.
1 procedure visit plus hospitalization for treatment and monitoring
Follow-up
Duration - Approximately 3 months (90 days ±14 days)
Participants are monitored for recovery, functional outcomes, and safety up to 90 days after treatment.
Multiple follow-up visits including assessments at 24 hours, 5 days or discharge, and 90 days
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Using Methinks AI Software to Speed Up Transfer Decisions for Acute Stroke Patients Needing Thrombectomy
Optimizing Intravenous Tenecteplase Use for Acute Ischemic Stroke Comparing Standard and Low Doses with No Tenecteplase in Emergency Treatment
Safety and Efficacy of Anakinra for Acute Ischemic Stroke After Endovascular Treatment Comparing Different Doses with Standard Care
Endovascular Therapy Using Automated Plain CT for Stroke Patients Treated 6 to 72 Hours After Symptoms Start
Study of Nurse-Led Stroke Transitional Care Program Effects on Stroke Survivors and Caregivers in Tanzania
Improving Emergency Telephone Triage Using Artificial Intelligence to Detect Critical Conditions Like Cardiac Arrest, Respiratory Distress, Chest Pain, and Stroke at the Andalusia Emergency Coordination Center
Study of Fusion Imaging Added to Standard Endovascular Thrombectomy in Adults With Acute Ischemic Stroke
Study of Immersive Virtual Reality Added to Conventional Rehabilitation for Upper-Limb Recovery After Acute Stroke
Examining Effects on Motor Function, Quality of Life, and Blood Biomarkers Related to Neuroplasticity
Phase 2 Trial Comparing Maraviroc to Placebo to Improve Motor Skills After Ischemic Stroke
Evaluating the Effects of Music Therapy on Sleep and Mood in Hospitalized Stroke Patients at San Cecilio University Hospital
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
Tudor G Jovin, Raul G Nogueira, Maarten G Lansberg...